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to view.Annular Rupture During Transcatheter Aortic Valve Replacement: Classiﬁcation,
Pathophysiology, Diagnostics, Treatment Approaches, and Prevention1Miralem Pasic, Axel Unbehaun, Semih Buz, Thorsten Drews, Roland HetzerAnnular rupture is an umbrella term covering different procedural-related injuries that may occur
in the region of the aortic root and the left ventricular outﬂow tract during transcatheter aortic
valve replacement. According to the anatomical location of the injury, there are 4 main types:
supra-annular, intra-annular, subannular, and combined rupture. Treatment approaches include
conventional cardiac procedure, isolated pericardial drainage, and conservative therapy. This
summary describes theoretical and practical considerations of the etiology, pathophysiology,
classiﬁcation, natural history, diagnostic and treatment strategies, and prevention approaches of
annular rupture.CLINICAL RESEARCH
CORONARY The Impact of Extreme-Risk Cases on Hospitals’ Risk-Adjusted Percutaneous
Coronary Intervention Mortality Ratings10Matthew W. Sherwood, J. Matthew Brennan, Kalon K. Ho, Frederick A. Masoudi,
John C. Messenger, W. Douglas Weaver, David Dai, Eric D. PetersonTo address concerns that treating percutaneous coronary intervention (PCI) patients with high-risk
features may adversely impact hospital performance ratings, Sherwood et al. examined a validated
risk-adjustment model in high-risk PCI cases to assess whether sites’ case mix affects their
performance ratings. Their study sample included 624,286 PCI procedures at 1,168 sites from the
CathPCI Registry in 2010. Crude in-hospital PCI mortality was 1.4%. The V4 NCDR PCI risk-adjusted
mortality (RAM) model was well calibrated among high-risk cases. Hospitals treating the highest
overall expected risk PCI patients had lower (better) RAM ratings than centers treating lower-risk
cases (1.25% vs. 1.51%). Combining high-risk patients over a 2-year period into a single year did
not negatively impact sites’ RAM ratings. There was no evidence that treating high-risk PCI cases
adversely affects hospital RAM rates.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
The Public Reporting Risk of Performing High-Risk Procedures: Perception or Reality? 17
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JANUARY 2015 VOLUME 8, NUMBER 1, PART AAccess Site Practice and Procedural Outcomes in Relation to Clinical Presentation
in 439,947 Patients Undergoing Percutaneous Coronary Intervention in the
United Kingdom20Karim Ratib, Mamas A. Mamas, Simon G. Anderson, Gurbir Bhatia, Helen Routledge,
Mark De Belder, Peter F. Ludman, Douglas Fraser, James Nolan, for the British
Cardiovascular Intervention Society and the National Institute for Cardiovascular
Outcomes ResearchThe inﬂuence of access site on patient outcomes was studied in 439,947 procedures from the
BCIS (British Cardiovascular Intervention Society) database. This study with a high proportion of
transradial access (TRA) procedures (210,260) observed an association with TRA and reduced
bleeding and access site complications in stable, non–ST-segment elevation acute coronary
syndrome (NSTEACS) and STEACS presentations. An association with reduced major adverse cardiac
events was observed in NSTEACS and STEACS. The same associations were observed in a matched
cohort comparing TRA to femoral access using closure devices. This suggests the effects observed
in randomized trials translate into real patient beneﬁts in routine practice.
Comparison of Sirolimus-Eluting Stenting With Minimally Invasive Bypass Surgery
for Stenosis of the Left Anterior Descending Coronary Artery: 7-Year Follow-Up
of a Randomized Trial30Stephan Blazek, Cornelius Rossbach, Michael A. Borger, Georg Fuernau, Steffen Desch,
Ingo Eitel, Thomas Stiermaier, Philipp Lurz, David Holzhey, Gerhard Schuler,
Friedrich-Wilhelm Mohr, Holger ThieleThis analysis assessed the 7-year long-term outcomes of a randomized comparison of percutaneous
coronary intervention (PCI) with sirolimus-eluting stents versus minimally invasive direct coronary
artery bypass (MIDCAB) surgery for the treatment of isolated proximal left anterior descending
lesions. Follow-up was conducted in 129 patients at a median time of 7.3 years (interquartile range:
5.7 to 8.3 years). At 7-year follow-up, PCI by sirolimus-eluting stents and MIDCAB in isolated
proximal left anterior descending lesions yielded similar long-term outcomes regarding the primary
composite clinical endpoint (22% PCI vs. 12% MIDCAB; p ¼ 0.17) and quality of life. Target vessel
revascularization was more frequent in the PCI group (20% vs. 1.5%; p < 0.001).CONTINUED ON PAGE A-24
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JANUARY 2015 VOLUME 8, NUMBER 1, PART AAn Angiographic Tool for Risk Prediction of Side Branch Occlusion in
Coronary Bifurcation Intervention: The RESOLVE Score System (Risk prEdiction
of Side branch OccLusion in coronary bifurcation interVEntion)39Kefei Dou, Dong Zhang, Bo Xu, Yuejin Yang, Dong Yin, Shubin Qiao, Yongjian Wu,
Hongbing Yan, Shijie You, Yang Wang, Zhenqiang Wu, Runlin Gao, Ajay J. KirtaneThe RESOLVE (Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion) score
system aimed to stratify the risk of side branch (SB) occlusion in patients undergoing coronary
bifurcation intervention. A total of 1,545 consecutive patients with 1,601 bifurcation lesions were
used to construct and validate the risk model and score system. In multivariable analyses,
6 variables were independently associated with the risk of SB occlusion (model C-statistic ¼ 0.80
[95% conﬁdence interval: 0.75 to 0.85] with good calibration). The SB occlusion rates in both
the construction and validation cohort increased signiﬁcantly across different risk groups. The
RESOLVE score can help identify patients at risk for SB occlusion during bifurcation intervention.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
When You Ask Yourself the Question “Should I Protect
the Side Branch?”: The Answer Is “Yes”47Antonio Colombo, Neil Ruparelia
Middle-of-the-Night Percutaneous Coronary Intervention and its Association
With Percutaneous Coronary Intervention Outcomes Performed the Following Day:
An Analysis From the National Cardiovascular Data Registry49Herbert D. Aronow, Hitinder S. Gurm, James C. Blankenship, Charles A. Czeisler,
Tracy Y. Wang, Lisa A. McCoy, Megan L. Neely, John A. SpertusAronow et al. compared in-hospital mortality and bleeding complications for PCI procedures
performed by sleep-deprived versus non–sleep-deprived operators using CathPCI registry data. Our
cohort included 1,509,096 daytime percutaneous coronary intervention procedures performed by
5,014 operators. In adjusted analyses, when comparing procedures performed by acutely sleep-
deprived with non–sleep-deprived operators, there were no signiﬁcant differences in mortality
(odds ratio [OR]: 1.02; 95% conﬁdence interval [CI]: 0.94 to 1.12; p ¼ 0.61) or bleeding (OR: 1.03;
95% CI: 0.98 to 1.08; p ¼ 0.19). However, a greater degree of chronic sleep deprivation was
associated with a higher adjusted risk of bleeding (OR: 1.19; 95% CI: 1.05 to 1.34; p ¼ 0.007).
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
Should Interventionalist Work Hours Be Restricted After a Night on Call? 57
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CONTENTS
PAGE A-25
JANUARY 2015 VOLUME 8, NUMBER 1, PART ASTRUCTURAL Predictors and Clinical Outcomes of Permanent Pacemaker Implantation After
Transcatheter Aortic Valve Replacement: The PARTNER (Placement of
AoRtic TraNscathetER Valves) Trial and Registry60Tamim M. Nazif, José M. Dizon, Rebecca T. Hahn, Ke Xu, Vasilis Babaliaros,
Pamela S. Douglas, Mikhael F. El-Chami, Howard C. Herrmann, Michael Mack,
Raj R. Makkar, D. Craig Miller, Augusto Pichard, E. Murat Tuzcu, Wilson Y. Szeto,
John G. Webb, Jeffrey W. Moses, Craig R. Smith, Mathew R. Williams, Martin B. Leon,
Susheel K. Kodali, for the PARTNER Publications OfﬁceConduction disturbances requiring permanent pacemaker (PPM) remain a frequent complication
of transcatheter aortic valve replacement (TAVR). This study included patients without prior
pacemaker who underwent TAVR in the PARTNER (Placement of AoRtic TraNscathetER Valves)
trial and registry and investigated the predictors and clinical effect of new PPM. In this
population, PPM was required in 173 of 1,973 patients (8.8%). By multivariable analysis,
independent predictors of PPM included right bundle branch block, prosthesis to left ventricular
(LV) outﬂow tract diameter ratio, LV end-diastolic diameter, and continued access registry.
Patients requiring PPM had longer post-procedure hospitalizations and signiﬁcantly higher 1-year
repeat hospitalization and mortality or repeat hospitalization. There were no signiﬁcant differences
in mortality or LV ejection fraction at 1 year.n EDITORIAL COMMENT
Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement:
Still a Concern?70Marina Urena, Josep Rodés-Cabau
Extended Use of Percutaneous Edge-to-Edge Mitral Valve Repair Beyond EVEREST
(Endovascular Valve Edge-to-Edge Repair) Criteria: 30-Day and 12-Month Clinical and
Echocardiographic Outcomes From the GRASP (Getting Reduction of Mitral Insufﬁciency
by Percutaneous Clip Implantation) Registry74Guilherme F. Attizzani, Yohei Ohno, Davide Capodanno, Stefano Cannata,
Fabio Dipasqua, Sebastiano Immé, Sarah Mangiaﬁco, Marco Barbanti,
Margherita Ministeri, Anna Cageggi, Anna Maria Pistritto, Sandra Giaquinta,
Silvia Farruggio, Marta Chiarandà, Giuseppe Ronsivalle, Audrey Schnell,
Salvatore Scandura, Corrado Tamburino, Piera Capranzano, Carmelo GrassoThe indications of percutaneous edge-to-edge mitral valve repair with the MitraClip system are
currently limited by strict echocardiographic criteria. Broadening indications for this therapy could
potentially beneﬁt a large number of patients that are referred to isolated medical management,
likely carrying poor long-term prognosis. In the present study, patients that fulﬁlled the expanded
echocardiographic criteria demonstrated similar safety at 30-day follow-up and efﬁcacy through
12-month follow-up after MitraClip implantation compared with safety and efﬁcacy in the control
(i.e., strict criteria) group. Furthermore, both groups revealed statistically signiﬁcant left ventricle
reverse remodeling at 12 months, but the between-group baseline differences were sustained.CONTINUED ON PAGE A-26
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JANUARY 2015 VOLUME 8, NUMBER 1, PART ATransfemoral Implantation of Transcatheter Heart Valves After Deterioration
of Mitral Bioprosthesis or Previous Ring Annuloplasty83Claire Bouleti, Amir-Ali Fassa, Dominique Himbert, Eric Brochet, Gregory Ducrocq,
Mohammed Nejjari, Walid Ghodbane, Jean-Pol Depoix, Patrick Nataf, Alec VahanianBouleti et al. evaluated the results of transfemoral implantation of an Edwards Sapien prosthesis in 17
patients after failed mitral bioprosthesis (n ¼ 6) and ring annuloplasty (n ¼ 11). All patients were in
New York Heart Association class $III with a high surgical risk (Society of Thoracic Surgeons score
18  22%). Procedure was successful in 14 patients (82%). The 18-month survival was 78  14%
for patients with elective procedure. At last follow-up, 75% of patients were in New York Heart
Association class #II. Transfemoral transcatheter heart valve implantation for deterioration of
mitral bioprosthesis or surgical repair provides encouraging immediate and midterm results and
may be considered for patients unsuitable for surgery or at very high surgical risk.PERIPHERAL Randomized Controlled Study of Excimer Laser Atherectomy for Treatment
of Femoropopliteal In-Stent Restenosis: Initial Results From the EXCITE ISR Trial
(EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal
In-Stent Restenosis)92Eric J. Dippel, Prakash Makam, Richard Kovach, Jon C. George, Raghotham Patlola,
D. Christopher Metzger, Carlos Mena-Hurtado, Robert Beasley, Peter Soukas,
Pedro J. Colon-Hernandez, Matthew A. Stark, Craig Walker, on behalf of the
EXCITE ISR InvestigatorsFemoropopliteal stenting for treatment of peripheral arterial disease (PAD) continues to increase.
However, in-stent restenosis (ISR) remains a challenging therapeutic problem due to procedural
complications and repeat restenosis. The multicenter, prospective, randomized, controlled EXCITE
ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent
Restenosis) trial enrolled 250 subjects to evaluate the safety and efﬁcacy of excimer laser
atherectomy (ELA) with adjunctive percutaneous transluminal angioplasty (PTA) versus PTA alone
for treating chronic PAD patients with femoropopliteal ISR. ELA + PTA and PTA subject 6-month
freedom from TLR was 73.5% versus 51.8% (p < 0.005), and 30-day major adverse event
rates were 5.8% versus 20.5% (p < 0.001), respectively. ELA + PTA was associated with a
52% reduction in TLR (hazard ratio: 0.48; 95% conﬁdence interval: 0.31 to 0.74).
SEE ADDITIONAL CONTENT ONLINECONTINUED ON PAGE A-27
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JANUARY 2015 VOLUME 8, NUMBER 1, PART AAngioplasty of Femoral-Popliteal Arteries With Drug-Coated Balloons:
5-Year Follow-Up of the THUNDER Trial102Gunnar Tepe, Beatrix Schnorr, Thomas Albrecht, Klaus Brechtel, Claus D. Claussen,
Bruno Scheller, Ulrich Speck, Thomas ZellerThe THUNDER (Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries)
investigated the treatment of femoropopliteal arteries with a paclitaxel-coated balloon (PCB). Over
5 years, the cumulative number of patients with target lesion revascularization remained
signiﬁcantly lower in the PCB group (21%) than in the uncoated control group (56%, p ¼ 0.0005). In
the small group of patients with angiographic and duplex sonographic follow-up, PCB was
associated with a lower rate of binary restenosis (17% vs. 54%; p ¼ 0.04). A beneﬁt of PCB
treatment in terms of late lumen loss and target lesion revascularization was seen independent
of lesion length.n EDITORIAL COMMENT
The THUNDER Trial Results: Clearing the Way or Ushering the Storm? 109
Michael R. JaffIMAGES IN
INTERVENTIONMitraClip Implantation in a Previous Surgical Mitral Valve Edge-to-Edge Repair 111
Vera E. Bottari, Gloria Tamborini, Antonio L. Bartorelli, Francesco Alamanni, Mauro Pepi
Giant Coronary Aneurysm Diagnosed as Incidental Mediastinal Mass 114
Roderick C. Deaño, Ashish M. Shah, Zarrish S. Khan, Geoffrey Bergman, Mary J. Roman,
Rajesh V. Swaminathan, Luke K. Kim, Dmitriy N. Feldman, Robert M. Minutello,
S. Chiu Wong, Navneet Narula, Arash Salemi, Harsimran S. Singh
Side Branch Occlusion After Bioresorbable Vascular Scaffold Implantation:
Lessons From Optimal Coherence Tomography116Katsumasa Sato, Vasileios F. Panoulas, Hiroyoshi Kawamoto, Toru Naganuma,
Tadashi Miyazaki, Azeem Latib, Antonio Colombo
n ONLINE FEATURE Impingement of Left Main Ostium After Device Occlusion
of Paravalvular Leak Post-Transcatheter Aortic Valve Replacemente1Matthew J. Price, Maulik G. Shah, Robert F. Burke, Robert D. Riley, David G. Rizik
n ONLINE FEATURE Endovascular Repair of Ruptured Pseudoaneurysm of
Left Internal Mammary Graft Following Redo Aortic Valve Replacement and
Coronary Artery Bypass Graftinge3Sanjeev U. Nair, Nainesh C. Patel, David A. Cox
n ONLINE FEATURE In-Scaffold Restenosis in a Previous Left Main Bifurcation
Lesion Treated With Bioresorbable Scaffold V-Stentinge7Tadashi Miyazaki, Vasileios F. Panoulas, Katsumasa Sato, Hiroyoshi Kawamoto,
Toru Naganuma, Azeem Latib, Antonio ColomboCONTINUED ON PAGE A-28
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JANUARY 2015 VOLUME 8, NUMBER 1, PART An ONLINE FEATURE Optical Coherence Tomography Assessment of Late
Intra-Scaffold Dissection: A New Challenge of Bioresorbable Scaffoldse11Yohei Ohno, Andrea Mangiameli, Guilherme F. Attizzani, Davide Capodanno,
Corrado Tamburino
n ONLINE FEATURE Occlusion of Balloon-Expandable Stent in the
Common Iliac Artery Due to Compression by a Spinal Spure13Hiroshi Fujita, Tomomitsu Tani, Tsuyoshi Ito, Nobuyuki Ohte
n ONLINE FEATURE THESE ARTICLES DO NOT APPEAR IN THE PRINTED ISSUE.
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THE EDITORAnatomic Guided Crossing of a Stenotic Aortic Valve Under Fluoroscopy:
“Right Cusp Rule, Part III”119Albert M. Kasel, Anupama Shivaraju, Wolfgang von Scheidt, Adnan Kastrati,
Christian Thilo
Calciﬁed Nodule Mimicking Red Thrombus on Optical Coherence Tomography 120
Fernando Alfonso, Javier Cuesta, Teresa Bastante, Fernando Rivero, Santiago Jiménez
Reply
Hiroyuki Hao
The Optimal Cutoff Value for Left Main Minimal Lumen Area of 4.5 mm2:
A Word of Caution122Jose M. de la Torre Hernández, Felipe Hernández, Fernando Alfonso
Reply
Seung-Jung Park, Soo-Jin Kang, Jung-Min Ahn
Intracardiac Echocardiographic Imaging of the Left Atrial Appendage
and Detection of a Peridevice Leak After Device Occlusion124Jian-Fang Ren, David J. Callans, Francis E. Marchlinski
Reply
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